Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo says executives appear to have broken Chinese law
Yahoo/Reuters
Monday, July 22, 2013 - 10:16am
tags:
GSK, China
Bizarre Protection Against Alzheimer's: Cancer
Motley Fool
Sunday, July 21, 2013 - 11:39am
tags:
Eli Lilly, Merck
5 Drugmakers With a Lot on the Line Next Week
Motley Fool
Sunday, July 21, 2013 - 11:37am
tags:
Eli Lilly, InterMune, Gilead Sciences, Alexion, Biomarin
Amgen's Acquisition Ambition Leads Biotechs' Rise
Motley Fool
Sunday, July 21, 2013 - 11:36am
tags:
Amgen, M&A
TWi Pharma's reduced food effect metformin controlled release formulation gets US patent
Pharmabiz
Saturday, July 20, 2013 - 12:07pm
tags:
TWi Pharmaceuticals, diabetes, metformin
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, July 20, 2013 - 11:54am
tags:
Vivus, Cempra, Corcept Therapeutics
Wockhardt gets warning letter from USFDA over Waluj plant
Economic Times, India
Saturday, July 20, 2013 - 11:53am
tags:
Wockhardt
OncoMed: High Opening Day Returns For This Biotech Public Offering
Seeking Alpha
Saturday, July 20, 2013 - 11:52am
tags:
OncoMed
Can This Pharmaceutical Power Stay Healthy?
Daily Finance
Saturday, July 20, 2013 - 11:51am
tags:
JNJ
Can Merck Finally Get Past the Vioxx Scandal?
Wall Street Cheat Street
Saturday, July 20, 2013 - 11:27am
tags:
Merck, Vioxx, lawsuits
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Saturday, July 20, 2013 - 11:26am
tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C, Bristol-Myers Squibb, Idenix
Alnylam Targets New Highs On Data Supporting RNAi
Seeking Alpha
Saturday, July 20, 2013 - 11:18am
tags:
RNA interference, Alnylam
Pacira Reports New Data
Yahoo/Zacks
Saturday, July 20, 2013 - 11:12am
tags:
Pacira, EXPAREL, pain management
Cytori Surges on Medistem Agreement
Yahoo/Zacks
Saturday, July 20, 2013 - 11:10am
tags:
Cytori, MediStem, stem cells
Chelsea's NDA for Northera Accepted
Yahoo/Zacks
Saturday, July 20, 2013 - 11:09am
tags:
Chelsea Therapeutics, Northera, neurogenic orthostatic hypotension
CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan
Yahoo/BusinessWire
Saturday, July 20, 2013 - 11:08am
tags:
Cel-Sci
BioCryst Pharmaceuticals: A Winning Investment For The Long Term
Seeking Alpha
Saturday, July 20, 2013 - 11:07am
tags:
Biocryst
Is This Biopharmaceutical Company Ahead Of Its Time?
Motley Fool
Saturday, July 20, 2013 - 11:05am
tags:
Regeneron
Vivus Said to Be Close to Settlement With First Manhattan
Bloomberg
Saturday, July 20, 2013 - 11:04am
tags:
Vivus
Pipeline Progress at Synergy Pharma
Yahoo/Zacks
Saturday, July 20, 2013 - 11:03am
tags:
Synergy Pharmaceuticals, irritable bowel syndrome, plecanatide

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.